Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide
Aim: Dimethylsulfoxide (DMSO) is the most frequently used agent for hematopoietic cell (HC) graft cryopreservation. This study
 aimed to monitor blood pressure and heart rate (HR) during HC graft infusion and assess the impact of cryopreservation with
 DMSO. Methods: 153 HC graft inf...
Gespeichert in:
| Veröffentlicht in: | Experimental Oncology |
|---|---|
| Datum: | 2009 |
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | Englisch |
| Veröffentlicht: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2009
|
| Schlagworte: | |
| Online Zugang: | https://nasplib.isofts.kiev.ua/handle/123456789/135722 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Zitieren: | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide / J.M. Horacek, L. Jebavy, M. Jakl, P. Zak, P. Mericka, J. Maly // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 121–122. — Бібліогр.: 15 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of Ukraine| _version_ | 1862745167602122752 |
|---|---|
| author | Horacek, J.M. Jebavy, L. Jakl, M. Zak, P. Mericka, P. Maly, J. |
| author_facet | Horacek, J.M. Jebavy, L. Jakl, M. Zak, P. Mericka, P. Maly, J. |
| citation_txt | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide / J.M. Horacek, L. Jebavy, M. Jakl, P. Zak, P. Mericka, J. Maly // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 121–122. — Бібліогр.: 15 назв. — англ. |
| collection | DSpace DC |
| container_title | Experimental Oncology |
| description | Aim: Dimethylsulfoxide (DMSO) is the most frequently used agent for hematopoietic cell (HC) graft cryopreservation. This study
aimed to monitor blood pressure and heart rate (HR) during HC graft infusion and assess the impact of cryopreservation with
DMSO. Methods: 153 HC graft infusions in 153 consecutive hematological patients (mean age 49.1 ± 12.6 years; 80 males) were
evaluated. Cryopreservation with DMSO was used in 133 grafts (DMSO group). Twenty grafts were infused directly without cryopreservation
(control group). Systolic blood pressure (SBP), diastolic blood pressure (DBP) and HR were measured immediately
before and after HC graft infusion. Results: SBP and DBP increased significantly after graft infusions cryopreserved with DMSO
(p < 0.0001 for SBP; p < 0.01 for DBP). Increases (> 10 mmHg) in SBP were seen in 42 (31.6%) patients; in DBP in 31 (23.3%)
patients. Changes in HR were non-significant in DMSO group. Increases in BP and HR correlated with increasing DMSO dose
(p < 0.01; p < 0.05, respectively). Changes in SBP, DBP and HR were non-significant in control group. Conclusion: HC graft
infusions cryopreserved with DMSO could cause statistically significant increases in SBP and DBP, without changes in HR. These
changes were mostly transient and asymptomatic, not requiring therapeutic intervention. However, they might cause complications,
especially in patients with preexisting cardiovascular disease, who should be monitored closely during HC transplantation.
|
| first_indexed | 2025-12-07T20:39:27Z |
| format | Article |
| fulltext | |
| id | nasplib_isofts_kiev_ua-123456789-135722 |
| institution | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| issn | 1812-9269 |
| language | English |
| last_indexed | 2025-12-07T20:39:27Z |
| publishDate | 2009 |
| publisher | Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| record_format | dspace |
| spelling | Horacek, J.M. Jebavy, L. Jakl, M. Zak, P. Mericka, P. Maly, J. 2018-06-15T14:20:01Z 2018-06-15T14:20:01Z 2009 Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide / J.M. Horacek, L. Jebavy, M. Jakl, P. Zak, P. Mericka, J. Maly // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 121–122. — Бібліогр.: 15 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/135722 Aim: Dimethylsulfoxide (DMSO) is the most frequently used agent for hematopoietic cell (HC) graft cryopreservation. This study
 aimed to monitor blood pressure and heart rate (HR) during HC graft infusion and assess the impact of cryopreservation with
 DMSO. Methods: 153 HC graft infusions in 153 consecutive hematological patients (mean age 49.1 ± 12.6 years; 80 males) were
 evaluated. Cryopreservation with DMSO was used in 133 grafts (DMSO group). Twenty grafts were infused directly without cryopreservation
 (control group). Systolic blood pressure (SBP), diastolic blood pressure (DBP) and HR were measured immediately
 before and after HC graft infusion. Results: SBP and DBP increased significantly after graft infusions cryopreserved with DMSO
 (p < 0.0001 for SBP; p < 0.01 for DBP). Increases (> 10 mmHg) in SBP were seen in 42 (31.6%) patients; in DBP in 31 (23.3%)
 patients. Changes in HR were non-significant in DMSO group. Increases in BP and HR correlated with increasing DMSO dose
 (p < 0.01; p < 0.05, respectively). Changes in SBP, DBP and HR were non-significant in control group. Conclusion: HC graft
 infusions cryopreserved with DMSO could cause statistically significant increases in SBP and DBP, without changes in HR. These
 changes were mostly transient and asymptomatic, not requiring therapeutic intervention. However, they might cause complications,
 especially in patients with preexisting cardiovascular disease, who should be monitored closely during HC transplantation. The work was supported by research projects MO
 0FVZ 0000503 (Czech Ministry of Defence) and MZO
 00179906 (Czech Ministry of Health). en Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України Experimental Oncology Short communications Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide Article published earlier |
| spellingShingle | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide Horacek, J.M. Jebavy, L. Jakl, M. Zak, P. Mericka, P. Maly, J. Short communications |
| title | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide |
| title_full | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide |
| title_fullStr | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide |
| title_full_unstemmed | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide |
| title_short | Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide |
| title_sort | cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients — impact of cryopreservation with dimethylsulfoxide |
| topic | Short communications |
| topic_facet | Short communications |
| url | https://nasplib.isofts.kiev.ua/handle/123456789/135722 |
| work_keys_str_mv | AT horacekjm cardiovascularchangesassociatedwithinfusionofhematopoieticcellgraftsinoncohematologicalpatientsimpactofcryopreservationwithdimethylsulfoxide AT jebavyl cardiovascularchangesassociatedwithinfusionofhematopoieticcellgraftsinoncohematologicalpatientsimpactofcryopreservationwithdimethylsulfoxide AT jaklm cardiovascularchangesassociatedwithinfusionofhematopoieticcellgraftsinoncohematologicalpatientsimpactofcryopreservationwithdimethylsulfoxide AT zakp cardiovascularchangesassociatedwithinfusionofhematopoieticcellgraftsinoncohematologicalpatientsimpactofcryopreservationwithdimethylsulfoxide AT merickap cardiovascularchangesassociatedwithinfusionofhematopoieticcellgraftsinoncohematologicalpatientsimpactofcryopreservationwithdimethylsulfoxide AT malyj cardiovascularchangesassociatedwithinfusionofhematopoieticcellgraftsinoncohematologicalpatientsimpactofcryopreservationwithdimethylsulfoxide |